IT1209512B - Procedimento selettivo per il blocco di ricettori di 5ht2. - Google Patents

Procedimento selettivo per il blocco di ricettori di 5ht2.

Info

Publication number
IT1209512B
IT1209512B IT8419995A IT1999584A IT1209512B IT 1209512 B IT1209512 B IT 1209512B IT 8419995 A IT8419995 A IT 8419995A IT 1999584 A IT1999584 A IT 1999584A IT 1209512 B IT1209512 B IT 1209512B
Authority
IT
Italy
Prior art keywords
receptors
blocking
selective procedure
selective
procedure
Prior art date
Application number
IT8419995A
Other languages
English (en)
Other versions
IT8419995A0 (it
Inventor
Marlene Lois Cohen
Ray Ward Fuller
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IT8419995A0 publication Critical patent/IT8419995A0/it
Application granted granted Critical
Publication of IT1209512B publication Critical patent/IT1209512B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Investigation Of Foundation Soil And Reinforcement Of Foundation Soil By Compacting Or Drainage (AREA)
  • Prostheses (AREA)
  • Holo Graphy (AREA)
  • Eye Examination Apparatus (AREA)
IT8419995A 1983-03-10 1984-03-09 Procedimento selettivo per il blocco di ricettori di 5ht2. IT1209512B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/473,882 US4563461A (en) 1983-03-10 1983-03-10 Selective method for blocking 5HT2 receptors

Publications (2)

Publication Number Publication Date
IT8419995A0 IT8419995A0 (it) 1984-03-09
IT1209512B true IT1209512B (it) 1989-08-30

Family

ID=23881404

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8419995A IT1209512B (it) 1983-03-10 1984-03-09 Procedimento selettivo per il blocco di ricettori di 5ht2.

Country Status (6)

Country Link
US (1) US4563461A (it)
EP (1) EP0122044B1 (it)
JP (1) JPS59175431A (it)
AT (1) ATE35506T1 (it)
DE (2) DE3408730A1 (it)
IT (1) IT1209512B (it)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
AU594373B2 (en) * 1985-10-01 1990-03-08 Eli Lilly And Company Esters of dihydrolysergic acid
US4906639A (en) * 1985-10-01 1990-03-06 Eli Lilly And Company Cycloalkanol esters of dihydrolysergic acid
US4762842A (en) * 1985-10-01 1988-08-09 Eli Lilly And Company Selective method for blocking 5HT2 receptors
US4939258A (en) * 1985-10-01 1990-07-03 Eli Lilly And Company Cycloalkanol esters of dihydrolysergic acid
US4968802A (en) * 1985-10-01 1990-11-06 Eli Lilly And Company Process of making alkoxy cycloalkanol esters of dihydrolysergic acid
US4845224A (en) * 1985-10-01 1989-07-04 Eli Lilly And Company Cycloalkanol esters of dihydrolysergic acid having peripheral serotonin antagonist properties
US4847261A (en) * 1985-10-01 1989-07-11 Eli Lilly And Company Alkoxy cycloalkanol esters of dihydrolysergic acid having peripheral serotonin antagonists properties
US4772709A (en) * 1985-10-01 1988-09-20 Eli Lilly And Company Process of making ketoalkanol esters of dihydrolysergic acid
US4683236A (en) * 1985-10-01 1987-07-28 Eli Lilly And Company Cycloalkanol esters of dihydrolysergic acid useful as 5Ht2 receptor antagonists
US4713385A (en) * 1985-10-01 1987-12-15 Eli Lilly And Company Alkoxy and dialkoxyalkyl esters of dihydrolysergic acid and related compounds useful as 5HT receptor antagonists
US4820713A (en) * 1985-10-01 1989-04-11 Eli Lilly And Company Ketoalkanol esters of dihydrolysergic acid useful as 5HT receptor antagonists
US4714704A (en) * 1985-10-01 1987-12-22 Eli Lilly And Company Alkoxy cycloalkanol esters of dihydrolysergic acid useful as 5HT receptor antagonists
US4810710A (en) * 1985-10-01 1989-03-07 Eli Lilly And Company 4-hydroxycyclohexyl 1-isopropyl-9,10-dihydro-lysergate for the treatment of migraine
US4713384A (en) * 1985-10-01 1987-12-15 Eli Lilly And Company Selective method for blocking 5HT2 receptors
US4704395A (en) * 1985-12-20 1987-11-03 Eli Lilly And Company Cyclic ether esters of 2-substituted-6-(substituted and unsubstituted) dihydrolysergic acid useful as 5HT receptor antagonists
US4704396A (en) * 1985-12-20 1987-11-03 Eli Lilly And Company Phenacyl esters of 1-substituted-6-(substituted and unsubstituted) dihydrolysergic acids useful as 5HT receptor antagonists
EP0228876A3 (en) * 1985-12-20 1989-03-22 Eli Lilly And Company Esters of dihydrolysergic acid and related compounds
US4683237A (en) * 1985-12-20 1987-07-28 Eli Lilly And Company Fluoroalkyl esters of dihydrolysergic acid useful as 5HT2 receptor antagonists
US5006526A (en) * 1988-10-17 1991-04-09 Louisiana State University Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
US5688807A (en) * 1994-03-11 1997-11-18 Eli Lilly And Company Method for treating 5HT2B receptor related conditions
US5886003A (en) * 1996-03-25 1999-03-23 Eli Lilly And Company Methods of treating or ameliorating the symptoms of venomous bites and stings
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249617A (en) * 1966-05-03 Alkylated d-lyserglc acid
US3228941A (en) * 1966-01-11 Methyl and i,g-dimethyl-ergoline i derivatives
CH344731A (de) * 1956-05-18 1960-02-29 Sandoz Ag Verfahren zur Herstellung von neuen, am Indolstickstoff alkylierten Derivaten der Lysergsäure-Reihe
US3580916A (en) * 1969-02-20 1971-05-25 Lilly Co Eli Hydroxyesters of hexa- and octahydroindoloquinolines
US3879554A (en) * 1970-03-20 1975-04-22 Farmaceutici Italia Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
GB1290203A (it) * 1970-09-01 1972-09-20
BE792515A (fr) * 1971-12-10 1973-06-08 Sandoz Sa Nouveaux derives de l'acide lysergique, leur preparation et leur application comme medicaments
JPS5443649B2 (it) * 1973-06-05 1979-12-21
US4153700A (en) * 1975-08-27 1979-05-08 Lake Shore Roentgenology Ltd. Treatment of the acute after-effects resulting from alcohol ingestion
YU40004B (en) * 1977-07-21 1985-06-30 Lek Tovarna Farmacevtskih Praocess for preparing n-substituted esters of 9,10-dihydrlysergic acid
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds

Also Published As

Publication number Publication date
IT8419995A0 (it) 1984-03-09
EP0122044A1 (en) 1984-10-17
JPS59175431A (ja) 1984-10-04
ATE35506T1 (de) 1988-07-15
EP0122044B1 (en) 1988-07-06
US4563461A (en) 1986-01-07
DE3408730A1 (de) 1984-09-13
DE3472529D1 (en) 1988-08-11

Similar Documents

Publication Publication Date Title
IT1209512B (it) Procedimento selettivo per il blocco di ricettori di 5ht2.
BG60249B2 (en) Thiazole compound for treatment of ulcers
NO934800D0 (no) Anvendelse av tetrahydrokarbazonderivater som 5HT1-reseptoragonis ter
IT1171879B (it) Derivati di 2-ammino-3-acilammino-6-benzilammino-piridina aventi azione antiepilettica
IE840182L (en) Des-proline vasopressin antagonists
ES519650A0 (es) Un procedimiento para obtener derivados de indanilbenzamida.
MX9101236A (es) Procedimiento para la preparacion de compuestos azabiciclicos
DE3880022T2 (de) Cycloalkylamide von (8beta)-1-alkyl-6-(substituierten) ergolinen.
FI952420A (fi) Glukopyranosidibentsotiofeenit
ES2132245T3 (es) Derivados de 1-azaadamantano como agonistas o antagonistas de 5-ht.
DK160093C (da) Analogifremgangsmaade til fremstilling af 2-(2-(1,4-benzodioxanyl))-2-imidazolderivater
FR2367761A1 (fr) Derives piperidylideniques de benzo-xanthenes,
ES511365A0 (es) "procedimiento de preparacion de derivados de fenetanolamina".
ES531099A0 (es) Un derivado de quinolina
SE8301725L (sv) Substituerade 3,4-diamino-1,2,5-tiadiazoler med histamin-h?712-receptor-antagonistaktivitet
ES499864A0 (es) Procedimiento para la preparacion de nuevas cefalosporinas
FR2572074B1 (fr) Derives du thiadiazole actifs sur le systeme nerveux central, procede d'obtention et compositions pharmaceutiques les contenant
SE8700566L (sv) Tetracykliska kinazolinoner
DE3361437D1 (en) 4-hydroxy-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxides, process for their preparation, their use and therapeutic agents containing them
JPS57136600A (en) Cis-c3",c4"-carbonate derivatives of o-demethyloleandomycin and intermediates
DE3362723D1 (en) Pyrido-triazoloquinazolines, their preparation and use
ZA817670B (en) 2-(n-aryl,n-1,2,3-thiadiazolylcarbonyl)-aminobutyrolactones,their preparation,fungicidal agents containing these compounds,and their use as fungicides